Atlas Trials

Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

Clinical trial NCT03741127 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03741127
Sponsor
Poseida Therapeutics, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2018-10-29
Primary completion
2032-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.